USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Shanghai Chuangshi Medical Technology (Group) Co., Ltd.

USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2022–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Shanghai ranks #20,396 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.

#20,396
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.4/100)
1.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R20396 · Foreign Corporation #20,396 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,396/49,997
  • PHOTO-FINISH SeedMaster Manufactu…
  • CPC-NARROW A61F · 5 areas
  • INNOV-THIN 38.4/100
  • CLAIMS-SPARSE 1.9 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2024 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: SeedMaster Manufacturing, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Shanghai’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Shanghai

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Shanghai's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Shanghai?

Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 1.9 claims/patent is at or below the 13.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 0510152025 Granted patents (volume) Avg claims / patent SeedMaster Manufacturing, Ltd. - 14, 18.93Seedmaster Manufa…Seismos, Inc. - 14, 21.14SeismosSenaya, Inc. - 14, 14.93SenayaShanghai Awinic Technology Co., Ltd. - 14, 13.5Shanghai Awinic T…Shanghai Huali Integrated Circuit Mfg. Co., Ltd. - 14, 14.36Shanghai Huali In…Shanghai Institute of Technical Physics Chinese Academy of Sciences - 14, 6.14Shanghai Institut…Shanghai Pharmaceuticals Holding Co., Ltd. - 14, 13.86Shanghai Pharmace…Shantou Chenghai District Lele Brothers Toys Co., Ltd - 14, 1Shantou Chenghai…Shanghai Chuangshi Medical Technology (Group) Co., Ltd. - 14, 1.86Shanghai Chuangsh…
Shanghai vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Shanghai's grants concentrate

Shanghai Chuangshi Medical Technology (Group) Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 7.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (7 grants) versus a trough of 1 in 2024. By volume, Shanghai sits between SeedMaster Manufacturing, Ltd. and Shantou Chenghai District Lele Brothers Toys Co., Ltd.

Shanghai's three-year grant acceleration

Shanghai Chuangshi Medical Technology (Group) Co., Ltd. shows 14 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Shanghai's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Shanghai holds 14 patents at rank #20,434, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Shanghai

By rank, the assignees closest to #20,434 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Shanghai's primary technology class.

Shanghai's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 202220232024 1
USPTO utility patent grants by year · 2022–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Shanghai Chuangshi Medical Technology (Group) Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 6 42.9%
2023 7 50.0%
2024 1 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Shanghai Chuangshi Medical Technology (Group) Co., Ltd.'s patent record in context - here's where to go next.

  • Shanghai Chuangshi Medical Technology (Group) Co., Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 7.1% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #20,396 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Shanghai Chuangshi Medical Technology (Group) Co., Ltd. against SeedMaster Manufacturing, Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.